Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
113,017
Sort by:
Prospects in the US Home Healthcare Market
US$ 700.00
Executive
The home health care industry is in its developing stage all over the world, US and Europe leads the market with the support of its developed economy and advancement in technology...
February 2011
41 pages
Building Strong Market Access Teams
US$ 395.00
A rock and a hard place. It’s not a comfortable spot to be, but increasingly, that’s where the pharmaceutical industry finds itself. Politicians in several European markets unilaterally cut prices for...
February 2011
36 pages
Competitor Analysis Interferon
US$ 619.00
Product description The Competitive Intelligence Report Interferon as of April 2014 provides a competitor analysis in the product portfolios and development pipelines of novel recombinant and natural interferon alpha, beta, gamma, lambda and of other subtypes for treatment of hepatitis B and C, other ...
February 2011
89 pages
Therapeutic Protein Pipeline Database: 1-Year Subscription
US$ 1,613.00
... order, e.g. for phase, product category or company name. Sample screenshots illustrate the database. Purchase of the subscription provides a 1-year online access to the data of the Therapeutic Protein Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase ...
February 2011
Booming Hospital Services Market in India
US$ 800.00
Single User PDF Format: US$ 800.00
Multi-User License: US$ 1,200.00
Hard Copy: US$ 900.00
CD-ROM: US$ 900.00 The hospital services market represents one of the most lucrative segments...
January 2011
80 pages
Asia Pacific Markets for Wound and Tissue Management 2011
US$ 8,495.00
... markets were valued at nearly $1.3 billion. The Asia Pacific wound and tissue management market is expected to be driven by the increasing aging population, rising ... Covidien, Ethicon, Kinetic Concepts Inc. and Smith & Nephew lead the market, among many others. This report provides a comprehensive and detailed ...
January 2011
489 pages
Global Physician Survey on Deep Vein Thrombosis Treatment and Screening 2011
US$ 11,495.00
... treatment methods, factors and product preferences for deep vein thrombosis. The Global Physician Survey on Deep Vein Thrombosis (DVT) includes: The ... Stents and their use for DVT treatment, including product preferences Deep Vein Thrombosis and imaging technologies Types of endovascular imaging used
January 2011
171 pages
Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatment 2011
US$ 11,495.00
... and treatment and endovascular imaging technologies. The Global Physician Survey on Stents, Stent-Grafts and Endovascular Imaging includes: The United ... Most Important Benefit When Using Bifurcated Stents Preferred Bifurcated Stent Alternative Bioabsorbable Stents and Their Use Most Important Benefit ...
January 2011
307 pages
Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO-IL-11)
US$ 259.00
The Competitive Intelligence Report Thrombopoiesis Stimulating Agents (TPO; IL-11) as of January 2011 provides information on thrombopoiesis stimulating agents targeting the thrombopoietin, interleukin-11 or other receptors on the market and in development. In addition, the report lists company-specific R&D ...
January 2011
21 pages
Competitor Analysis: G-CSF & GM-CSF
US$ 454.00
... report includes a compilation of currently marketed branded and non-branded G-CSF and GM-CSF products in regulated and non-regulated markets for treatment ... products in regulated markets 1st and next generation GM-CSF products in non-regulated markets About La Merie About Competitor Analysis Series: The ...
January 2011
40 pages
Competitor Analysis: Erythropoietin (EPO)
US$ 684.00
Product description The Competitive Intelligence Report Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) as of January 2011 in its 5th edition provides information on existing first and second generation epoetin products in regulated markets, an overview on biosimilar versions of EPO in ...
January 2011
76 pages
UK Private Healthcare Market Development Report
US$ 1,135.00
This MBD UK private health market research report covers the private healthcare sector comprising the provision of healthcare services through private hospitals and clinics, and the private medical in...
December 2010
79 pages
Digital Health Quarterly 1Q 2011 2Q 2011
US$ 1,500.00
The Market Tracker: Digital Health Quarterly offers in-depth analysis of the latest corporate news, industry events, passed and pending legislation, and government directives related to the digital health industry.
December 2010
20 pages
Digital Health Quarterly 2Q 2011 3Q 2011
US$ 1,500.00
The Market Tracker: Digital Health Quarterly offers in-depth analysis of the latest corporate news, industry events, passed and pending legislation, and government directives related to the digital health industry.
December 2010
18 pages
Digital Health Quarterly 3Q 2011 4Q 2011
US$ 1,500.00
The Market Tracker: Digital Health Quarterly offers in-depth analysis of the latest corporate news, industry events, passed and pending legislation, and government directives related to the digital health industry.
December 2010
16 pages
Digital Health Quarterly 4Q 2010 1Q 2011
US$ 1,500.00
The Market Tracker: Digital Health Quarterly offers in-depth analysis of the latest corporate news, industry events, passed and pending legislation, and government directives related to the digital health industry.
December 2010
20 pages
IP-based Health Solutions: Home Care and Beyond 4Q 2011
US$ 3,500.00
... report examines the market for IP-based monitoring solutions that help consumers live safer and healthier at home. It looks into broadband service ... Broadband in the home and wireless broadband connectivity have made it easier to remotely monitor consumers for safety and health concerns. IP-based sensor ...
December 2010
50 pages
Wireless Healthcare (Second Edition) 3Q 2011
US$ 3,500.00
... This report updates the inaugural wireless health report from Parks Associates. It continues to profile innovations in both wireless technology-supported personal health ... growth potentials. “Parks Associates believes that mobile technology and wireless connectivity will greatly enhance the appeal of personal health applications ...
December 2010
54 pages
Weight Loss Websites: A Market & Competitor Analysis
US$ 995.00
... groundbreaking new Marketdata study examines the crowded $842 million weight loss websites market. Research for this study was based on primary research ... study covers: Status of the overall weight loss market, nature/structure of the online dieting market, types of diet websites, revenue models used, how sites ...
December 2010
171 pages
Worldwide Market for Mobile Medical Apps
US$ 1,500.00
ProdUnitPrice (Single User PDF): $1,500.00
ProdUnit Price (Global Site License): $3,000.00 Smartphone and other mobile applications or “apps” are being utilized in many areas of healthcare: ed...
December 2010
60 pages
Worldwide Point of Care Diagnostic Test Markets
US$ 2,800.00
Diagnostic tests performed outside the central laboratory or decentralized testing is generally known as point-of-care (POC). Over the years, the increasing introduction of transportable, portable, an...
December 2010
390 pages
U.S. Market for Magnetic Resonance, Computed Tomography and Nuclear Medicine 2010
US$ 7,495.00
... : X-Ray/CT Contrast Agents MRI Contrast Agents Ultrasound Contrast Agents Contrast Injectors Within the magnetic resonance (MRI), computed tomography (CT) and nuclear medicine markets, companies such as Bracco, Covidien, GE Healthcare, Philips Healthcare and Siemens Healthcare lead the market. This ...
December 2010
149 pages
Closing the Loop: Beyond Digital Detailing
US$ 395.00
Imagine this: Nearly all the puzzle pieces are in place. The picture is clear, but not yet finished. One part remains. But no matter how you try, something stops it from fitting it in place. For the p...
November 2010
48 pages
Pricing and Private Label in Consumer Health
US$ 2,000.00
... burden on companies’ revenues. Consumers are buying inexpensive options, such as private label and generic products, as their purchasing power has decreased ... and branding strategies. Euromonitor International’s Pricing and Private Label in Consumer Health global briefing examines the size, growth trends and ...
November 2010
53 pages
pH Control/Salts: Ingredients for a Cleaner World?
US$ 2,000.00
... becoming more urbanised, the demand for home care products has never been so high. This is fuelling growth for pH control/salt ... report, highlighting opportunities for continued growth. Euromonitor International's pH Control/Salts: Ingredients for a Cleaner World? global briefing offers a comprehensive guide ...
November 2010
55 pages
Competitor Analysis: Sphingosine-1-Phosphate (S1P)
US$ 277.00
Product description The present Competitive Intelligence Report about Sphingosine-1-Phosphate (S1P) provides a competitor evaluation in the field of molecules interacting with the sphingosine-1-phosphate pathway as of November 2010. Among these molecules are S1P and selective S1P1 receptor agonists or S1P ...
November 2010
26 pages
Competitor Analysis p38 MAPK Inhibitors
US$ 273.00
... would be expected to decrease the production of these cytokines. About ten p38 MAPK inhibitors are in clinical phase I and II studies, with the first ... leading to the source of information. Index p38 MAPK Inhibitors p38 alpha MAPK Inhibitors About La Merie About Competitor Analysis Series: The ...
November 2010
21 pages
Competitor Analysis Interleukin-6 (IL-6) and Receptor (IL-6R) Antagonists
US$ 205.00
... IL-6R Antagonists in Inflammation IL-6 and IL-6R Antagonists in Oncology Small Molecule Approaches of IL-6 and IL-6R Antagonists About La Merie About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, ...
November 2010
20 pages
Romania Dental Market Analysis
US$ 400.00
Single User PDF Format: US$ 400.00 Multi-User License: US$ 800.00 Hard Copy: US$ 500.00 CD-ROM: US$ 500.00 Romania has emerged as one of the most popular destinations in Europe for dental treatments...
October 2010
30 pages
European Markets for Wound and Tissue Management 2011
US$ 11,495.00
... markets were valued at nearly €2.3 billion. The European markets for wound and tissue management covers 15 countries in Europe including Austria, Benelux, France, ... The products can be divided into external, internal and combined wound management. In 2009, the combined devices represented the largest segment ...
October 2010
410 pages
Global Probiotics and Prebiotics: Moving Beyond Digestive Health Status Quo
US$ 2,000.00
... functional ingredients of all times – providing regulatory hurdles can be overcome. Euromonitor International's Global Probiotics and Prebiotics: Moving Beyond Digestive Health Status Quo global briefing offers an insight into to the size and shape of the health and wellness marketplace, highlights ...
October 2010
57 pages
Wound Treatments - Venezuela
US$ 990.00
... from an increase in demand combined with above inflation price increases. Wound treatments remains in an early stage of development and demand is increasing rapidly as availability ... lower income consumers cannot afford such products. Euromonitor International's Wound Treatments in Venezuela report offers a comprehensive guide to the size and shape of the ...
October 2010
30 pages
Competitor Analysis Toll-Like Receptor (TLR) Agonists & Antagonists
US$ 800.00
... description The Competitive Intelligence Report Toll-Like Receptor (TLR) Agonists & Antagonists provides a competitor analysis in the development pipeline of novel small ... with the project data to print or export an individual report. Toll-like receptors (TLRs) are a class of proteins that play a key role ...
October 2010
144 pages
Global Minimally Invasive Surgery Market (2010 - 2015)
US$ 5,650.00
The technology shift from invasive to minimally invasive surgery (MIS) has brought about significant changes in the field of medicine. ... of critical micro-markets, which have so far remained unexplored. Scope of the report This research report categorizes the global market for minimally invasive surgery devices on the ...
October 2010
251 pages
Competitor Analysis: C5a-R Antagonists
US$ 173.00
... , Target / Mechanism of Action, Class of Compound, Company, Product Category, Indication, R&D Stage and additional comments with a hyperlink leading to the source of information. Index C5 Antagonists C5a Antagonists C5aR Antagonists Corporate C5a & C5aR Antagonist R&D Pipelines About La Merie
October 2010
14 pages
Tomorrow’s KOLs: the Changing Face of Influence
US$ 395.00
In Europe, the US and other key markets, the story is the same: regulatory change, public opinion and cost containment are all changing the face of stakeholders. Where physicians once spoke with the s...
September 2010
49 pages
REMS: A Standardized Approach to Risk Management
US$ 395.00
Risk Evaluation and Mitigation Strategies. Until recently, the Federal Drug Administration’s REMS program impacted drugs that would not have been otherwise approved due to their risks. The hurdles, co...
September 2010
42 pages
Abnormal Uterine Bleeding Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Abnormal Uterine Bleeding Therapy Area Pipeline Report contains detailed information on the abnormal uterine bleeding drug pipeline. This report provides insight into the pipe...
September 2010
47 pages
Acidity Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Acidity Therapy Area Pipeline Report contains detailed information on the acidity drug pipeline. This report provides insight into the pipeline status of acidity drugs by comp...
September 2010
255 pages
